Lien Vo - Concepedia

Author

Lien Vo

Janssen (United States)

Also Known As

Lien Vo, Lien Vo PharmD, Marie Synnestvedt

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Janssen (United States)Janssen Scientific Affairs (United States)Bristol-Myers Squibb (United States)Pfizer (United States)STATinMED (United States)

About

Lien Vo is an author at Janssen (United States) specializing in medicine, pharmacotherapy, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	434
2	Health Sciences	1	1	42
3	Biochemistry	1	1	51
4	Emergency Medicine	1	1	103
5	Epidemiology	1	1	97

Lien Vo

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Regional Postprandial Differences in pH Within the Stomach and Gastroesophageal Junction Hrair P. Simonian, Lien Vo, Siva Doma, Digestive Diseases and Sciences EsophagusGastroesophageal JunctionBiliary TractFood DigestionPhysiology	2005	141
Direct medical costs of complications of diabetes in the United States: estimates for event-year and annual state costs (USD 2012) Alex Ward, Piedad Alvarez, Lien Vo Journal of Medical Economics	2014	131
Imipenem Resistance in <i>Pseudomonas aeruginosa</i> Emergence, Epidemiology, and Impact on Clinical and Economic Outcomes Ebbing Lautenbach, Marie Synnestvedt, Mark G. Weiner, Infection Control and Hospital Epidemiology	2009	111
Epidemiology and Impact of Imipenem Resistance in <i>Acinetobacter baumannii</i> Ebbing Lautenbach, Marie Synnestvedt, Mark G. Weiner, Infection Control and Hospital Epidemiology	2009	103
Epidemiology and Outcomes of Complicated Skin and Soft Tissue Infections in Hospitalized Patients Marcus Zervos, Katherine Freeman, Lien Vo, Journal of Clinical Microbiology Soft Tissue InfectionsCa CsstiCssti OriginDermatologyLogistic Analysis	2011	103
Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: A multicenter cohort study Marin H. Kollef, Marya D. Zilberberg, Andrew F. Shorr, Journal of Infection Pathogenic MicrobiologyHealthcare-associated InfectionHospital EpidemiologyCommunity-acquired BacteremiaClinical Infection	2010	97
Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran or rivaroxaban compared with warfarin in the United States Medicare population Alpesh Amin, Allison Keshishian, Jeffrey Trocio, Current Medical Research and Opinion	2017	70
A prospective, multicenter, observational study of complicated skin and soft tissue infections in hospitalized patients: clinical characteristics, medical treatment, and outcomes Benjamin A. Lipsky, Gregory J. Moran, Lena M. Napolitano, BMC Infectious Diseases	2012	59
Drug Persistency of Two Cholinesterase Inhibitors Dong‐Churl Suh, Simu K. Thomas, Elmira Valiyeva, Drugs & Aging Pharmacological StudyBiochemistryMedicinePharmacological AgentPharmacotherapy	2005	51
Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice Derek Weycker, Xiaoyan Li, Gail Wygant, Thrombosis and Haemostasis	2018	45

Page 1